Loading clinical trials...
Loading clinical trials...
The Pathogenic Role of 11ß-hydroxysteroid Dehydrogenase in the Metabolic Syndrome - the Effect of Rosiglitazone
Conditions
Interventions
rosiglitazone
Locations
1
Germany
Charite, Campus Benjamin Franklin
Berlin, Germany
Start Date
May 1, 2004
Primary Completion Date
October 1, 2008
Completion Date
October 1, 2008
Last Updated
January 16, 2018
NCT07237750
NCT07460856
NCT06277661
NCT06715787
NCT07354438
NCT07330297
Lead Sponsor
Charite University, Berlin, Germany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions